相关实验视频

Updated: Jun 3, 2025

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

缺血性中风患者的地理位置会影响丹麦的血栓溶解可用性

E H Mortensen¹, J Wenstrup², S N F Blomberg³

¹Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.

Journal of the neurological sciences

|January 9, 2025

概括

在丹麦,较长的运输时间到中风复血管中心减少了静脉血栓溶解 (IVT) 率. 居住在60分钟以上距离的患者接受这一关键性中风治疗的可能性较低.

科学领域:

神经学神经学
公共卫生公共卫生
紧急医疗紧急医疗

背景情况:

及时治疗中风,特别是重血管治疗,对于患者的治疗结果至关重要.
长途运输到中风中心的距离可能会推迟关键干预.
本研究研究了运输时间和距离对丹麦中风患者接受静脉血栓溶解 (IVT) 的影响.

研究的目的:

调查运输时间和距离到中风复血管化装置之间的关联,以及接受IVT的可能性.
分析那些在中风症状出现后3小时内联系紧急医疗服务 (EMS) 的患者的数据.

主要方法:

利用了来自丹麦中风登记 (DanStroke) 和计算机辅助调度系统 (CAD) 的数据.
包括首都地区和西兰地区的中风患者,他们在症状出现后3小时内与EMS联系.
采用多变量后勤回归模型进行统计分析.

主要成果:

在首都地区,增加的运输时间与IVT率的下降相关 (OR 0.91,P=0.0386).
在西兰地区,运输时间和IVT率之间没有显著的相关性.
然而,西兰地区的患者在60分钟内从再血管化单位出发后,IVT率较低,而在0-20分钟内 (OR0.63,P=0.016) 的患者相比.

结论:

到中风中心的更长的运输时间会对首都地区的IVT率产生负面影响,丹麦.
虽然在西兰地区并不显著,但长时间旅行 (>60分钟) 与该地区IVT概率的降低有关.
优化医院前运输物流对于改善中风治疗可及性和结果至关重要.

关键词:

急性缺血性中风是一次急性缺血性中风.紧急医疗服务紧急医疗服务地理位置地理位置.血栓溶解是一种血栓溶解.

更多相关视频

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.